Prevalence and incidence of pituitary adenomas: A population based study in Malta

Pituitary

Volumn 16, Issue 4, 2013, Pages 545-553

  Gruppetta, Mark ^a,b   Mercieca, Cecilia ^a   Vassallo, Josanne ^a,b  

^a UNIVERSITY OF MALTA   (Malta)

^b MATER DEI HOSPITAL   (Malta)

Author keywords

Incidence; Pituitary adenoma; Prevalence

Indexed keywords

ADENOMA; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOCRINE SURGERY; EPIDEMIOLOGICAL DATA; EPIDEMIOLOGICAL MONITORING; FEMALE; FOLLOW UP; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; MAJOR CLINICAL STUDY; MALE; MALTA; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PREVALENCE RATE; PRIORITY JOURNAL; PROLACTINOMA; RADIOLOGY DEPARTMENT; RETROSPECTIVE STUDY; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; TRANSSPHENOIDAL SURGERY;

FEMALE; HUMANS; INCIDENCE; MALE; MALTA; PITUITARY NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84888197815     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-012-0454-0     Document Type: Article

References (23)

1. Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364-3369
2. Matta MP, Couture E, Cazals L, Vezzosi D, Bennet A, Caron P (2008) Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. Eur J Endocrinol 158:305-310
3. Van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69:775-784
4. Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS (2011) Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14:276-283
5. Siqueira MG, Guembarovski AL (1984) Subclinical pituitary microadenomas. Surg Neurol 22:134-140
6. Teramoto A, Hirakawa K, Sanno N, Osamura Y (1994) Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193:161-164
7. Tomita T, Gates E (1999) Pituitary adenomas and granular cell tumors: incidence, cell type, and location of tumor in 100 pituitary glands at autopsy. Am J Clin Pathol 111:817-825
8. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH (1994) Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120:817-820
9. Chong BW, Kucharczyk W, Singer W, George S (1994) Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas. Am J Neuroradiol 15:675-679
10. Mindermann T, Wilson CB (1994) Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 41:359-364
11. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85:1420-1425
12. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769-4775
13. Fernandez A, Karavitaki N, Wass JA (2009) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377-382
14. Fontana E, Gaillard R (2009) Epidemiology of pituitary adenoma: results of the first Swiss study. Rev Med Suisse 5:2172-2174
15. Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrinol Metab 95:4268-4275
16. Daly AF, Tichomirowa MA, Beckers A (2009) The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23:543-554
17. Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2000) Age standardization of rates: a new WHO standard. GPE discussion paper series 31. World Health Organization, Geneva
18. Davis JRE, Farrell WE, Clayton RN (2000) Pituitary tumours. Reproduction 121:363-371
19. Ciccarelli A, Daly AF, Beckers A (2005) The epidemiology of prolactinomas. Pituitary 8:3-6
20. Colao A (2009) The prolactinoma. Best Pract Res Clin Endocrinol Metab 23:575-596
21. Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23:667-675
22. Franks S, Nabarro JDN, Jacobs HS (1977) Prevalence and presentations of hyperprolactinaemia in patients with "functionless" pituitary tumours. Lancet 309:778-780
23. Murad MH, Fernández-Balsells MM, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Pérez L, Ponce de León-Lovatón PG, Albuquerque FN, Carey J, Erwin PJ, Montori VM (2010) Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 73:777-791